Gene · 406902
Papers3,238
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,238
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of N6-methyladenosine methylation in glioma: recent insights and future directions. | Cell Mol Biol Lett | 2023 | 38072944 | PubTator, text mining | PubMed |
| MicroRNAs as Potential Biomarkers of Environmental Exposure to Polycyclic Aromatic Hydrocarbons and Their Link with Inflammation and Lung Cancer. | Int J Mol Sci | 2023 | 38069307 | PubTator, text mining | PubMed |
| A Journey to Reach the Ovary Using Next-Generation Technologies. | Int J Mol Sci | 2023 | 38068916 | PubTator, text mining | PubMed |
| MiRNAs in Alcohol-Related Liver Diseases and Hepatocellular Carcinoma: A Step toward New Therapeutic Approaches? | Cancers (Basel) | 2023 | 38067261 | PubTator, text mining | PubMed |
| Secreted miR-210-3p, miR-183-5p and miR-96-5p reduce sensitivity to docetaxel in prostate cancer cells. | Cell Death Discov | 2023 | 38065937 | PubTator, text mining | PubMed |
| lncRNA TUSC7 regulates oxidative stress level by targeting miR-23b in colorectal cancer and thus inhibits cell proliferation, migration and invasion. | Aging (Albany NY) | 2023 | 38054829 | PubTator, text mining | PubMed |
| Upregulation of miR-194-5p or silencing of PRC1 enhances radiotherapy sensitivity in esophageal squamous carcinoma cells. | Heliyon | 2023 | 38046164 | PubTator, text mining | PubMed |
| NEDD4L in human tumors: regulatory mechanisms and dual effects on anti-tumor and pro-tumor. | Front Pharmacol | 2023 | 38027016 | PubTator, text mining | PubMed |
| Identification of miRNA Associated with Trichomonas gallinae Resistance in Pigeon (Columba livia). | Int J Mol Sci | 2023 | 38003649 | PubTator, text mining | PubMed |
| HCV and HCC Tango-Deciphering the Intricate Dance of Disease: A Review Article. | Int J Mol Sci | 2023 | 38003240 | PubTator, text mining | PubMed |
| Non-Coding RNAs as Potential Targets for Diagnosis and Treatment of Oral Lichen Planus: A Narrative Review. | Biomolecules | 2023 | 38002328 | PubTator, text mining | PubMed |
| Anticarcinogenic Potency of EF24: An Overview of Its Pharmacokinetics, Efficacy, Mechanism of Action, and Nanoformulation for Drug Delivery. | Cancers (Basel) | 2023 | 38001739 | PubTator, text mining | PubMed |
| Downregulation of Exosomal hsa-miR-551b-3p in Obesity and Its Link to Type 2 Diabetes Mellitus. | Noncoding RNA | 2023 | 37987363 | PubTator, text mining | PubMed |
| Gene dosage compensation: Origins, criteria to identify compensated genes, and mechanisms including sensor loops as an emerging systems-level property in cancer. | Cancer Med | 2023 | 37987212 | PubTator, text mining | PubMed |
| Stem cells and exosomes: as biological agents in the diagnosis and treatment of polycystic ovary syndrome (PCOS). | Front Endocrinol (Lausanne) | 2023 | 37964963 | PubTator, text mining | PubMed |
| MiR-200b categorizes patients into pancreas cystic lesion subgroups with different malignant potential. | Sci Rep | 2023 | 37963969 | PubTator, text mining | PubMed |
| Unraveling the Intricate Roles of Exosomes in Cardiovascular Diseases: A Comprehensive Review of Physiological Significance and Pathological Implications. | Int J Mol Sci | 2023 | 37958661 | PubTator, text mining | PubMed |
| Atherosclerosis and Its Related Laboratory Biomarkers. | Int J Mol Sci | 2023 | 37958528 | PubTator, text mining | PubMed |
| Menstrual blood-derived endometrial stem cell, a unique and promising alternative in the stem cell-based therapy for chemotherapy-induced premature ovarian insufficiency. | Stem Cell Res Ther | 2023 | 37957675 | PubTator, text mining | PubMed |
| Comprehensive Analysis of a Competing Endogenous RNA Co-Expression Network in Chronic Obstructive Pulmonary Disease. | Int J Chron Obstruct Pulmon Dis | 2023 | 37955025 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406902/papers?page=7